Lv0
0 积分 2024-03-07 加入
Orforglipron Added to Titrated Insulin Glargine in Type 2 Diabetes: The ACHIEVE-5 Randomized Clinical Trial
2天前
已完结
Orforglipron compared with dapagliflozin in adults with type 2 diabetes and inadequate glycaemic control with metformin (ACHIEVE-2): a multicentre, randomised, non-inferiority, open-label, phase 3 trial
2天前
已完结
Peptide GLP-1 receptor agonists: From injection to oral delivery strategies
3天前
已完结
Structural pharmacology and mechanisms of GLP-1R signaling
4天前
已完结
Early-onset type 2 diabetes: the next major diabetes transition
11天前
已完结
Separate and combined effect of visit‐to‐visit glycaemic variability and mean fasting blood glucose level on all‐cause mortality in patients with type 2 diabetes: A population‐based cohort study
11天前
已完结
β-cell dedifferentiation and type 2 diabetes
16天前
已完结
医生的自媒体时代
18天前
已完结
Osteoarthritis
23天前
已完结
育龄期超重/肥胖多囊卵巢综合征患者非药物体重管理的最佳证据总结
23天前
已完结
皖公网安备34019202002308
